Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Outcomes of Patients on a Phase II Prospective Trial of Oligometastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation and External Beam Radiation.
Hao C, Ladbury C, Lyou Y, Manoukian S, Ruel C, Frankel P, Dorff T, Wong J, Pal S, Twardowski P, Dandapani S. Hao C, et al. Among authors: lyou y. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):705-710. doi: 10.1016/j.ijrobp.2022.06.085. Epub 2022 Jul 5. Int J Radiat Oncol Biol Phys. 2022. PMID: 35803445 Review.
Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma.
Lyou Y, Grivas P, Rosenberg JE, Hoffman-Censits J, Quinn DI, P Petrylak D, Galsky M, Vaishampayan U, De Giorgi U, Gupta S, Burris H, Rearden J, Li A, Wang H, Reyes M, Moran S, Daneshmand S, Bajorin D, Pal SK. Lyou Y, et al. Eur Urol. 2020 Dec;78(6):916-924. doi: 10.1016/j.eururo.2020.08.002. Epub 2020 Aug 23. Eur Urol. 2020. PMID: 32847703 Free PMC article.
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
Pal SK, Frankel PH, Mortazavi A, Milowsky M, Vaishampayan U, Parikh M, Lyou Y, Weng P, Parikh R, Teply B, Dreicer R, Emamekhoo H, Michaelson D, Hoimes C, Zhang T, Srinivas S, Kim WY, Cui Y, Newman E, Lara PN Jr. Pal SK, et al. Among authors: lyou y. JAMA Oncol. 2021 Oct 1;7(10):1536-1543. doi: 10.1001/jamaoncol.2021.3441. JAMA Oncol. 2021. PMID: 34436521 Free PMC article. Clinical Trial.
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.
Lyou Y, Rosenberg JE, Hoffman-Censits J, Quinn DI, Petrylak D, Galsky M, Vaishampayan U, De Giorgi U, Gupta S, Burris H, Rearden J, Li A, Xu C, Andresen C, Moran S, Daneshmand S, Bajorin D, Pal SK, Grivas P. Lyou Y, et al. Clin Genitourin Cancer. 2022 Feb;20(1):35-42. doi: 10.1016/j.clgc.2021.10.004. Epub 2021 Oct 13. Clin Genitourin Cancer. 2022. PMID: 34782263 Free PMC article.
38 results